0920-0995 STD Tx Guidelines Short Long-Term Evaluation wordversion

National Network of Sexually Transmitted Disease Clinical Prevention Traning Centers (NNPTC)

Att 27 STD Tx Guidelines Short Long Term Evaluation wordversion

OMB: 0920-0995

Document [docx]
Download: docx | pdf


National Network of Sexually Transmitted Disease Clinical Prevention Training Centers (NNPTC): Evaluation

OMB No. 0920-0995










Attachments 27 & 28


Treatment Guidelines Short Long-term Evaluation Instrument

Word version and screenshot



TODAY’S DATE

____________________________

M M D D Y Y

Your confidential ID number is the first two letters of your FIRST name, the first two letters of your LAST name, the MONTH of your birth, and the DAY of your birth.









FN

FN

LN

LN

M

M

D

D

CONFIDENTIAL IDENTIFIER




Condensed STD Treatment Short Long-Term Evaluation


Public reporting burden of this collection of information is estimated to average 3minutes per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing the collection of information.  An agency may not conduct or sponsor, and a person is not required to respond to a collection of information unless it displays a currently valid OMB control number.  Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to CDC/ATSDR Reports Clearance Officer; 1600 Clifton Road NE, MS D-74, Atlanta, Georgia 30333; ATTN: PRA (0920-0995).


A8f. Did you incorporate any of the information presented into your patient care, practice setting or job?

Yes

No

Not applicable to my practice or patients

I was already performing the recommended practices

Other (please specify) ______________________________________

As a result of information presented in this training did you …


Yes

No

NA

I was already doing this

SGCH2f …download the CDC STD Treatment Guidelines app?

1

0

2

3

SGCH3f …increase the proportion of your sexually active asymptomatic female patients under age 25 screened for urogenital chlamydia and gonorrhea?

1

0

2

3

SGCH4f …increase the proportion of your male patients who have sex with men screened for syphilis, gonorrhea, and chlamydia at least annually?

1

0

2

3

SGCH5f …use dual antibiotic therapy to treat uncomplicated gonorrhea?

1

0

2

3

SGCH6f …send a consult to the STD Clinical Consultation Network? www.stdccn.org

1

0

2

3

SGCH7f …recommend rescreening in 3 months following a gonorrhea, chlamydia or trichomonas diagnosis?

1

0

2

3

SGCH8f use the STD Treatment Guidelines wall chart or pocket guide?

1

0

2

3

SGCH9f …share information about the STD Treatment Guidelines with others?

1

0

2

3


EPTf As a result of information presented in this training did you provide Expedited Partner Therapy (EPT) to

heterosexual partners of those diagnosed with gonorrhea and/or chlamydia?

Yes

No

Not applicable to my practice or job

Not allowed in my state/practice

My practice/worksite is in the planning stages to offer EPT

My practice/worksite already offered EPT

EPT was not discussed


A6f. Did any of these factors MAKE IT HARDER for you to incorporate the STD practices recommended in the presentation? (select all that apply)

 lack of time with patients

 more important patient concerns

 cost/lack of reimbursement

 policies where I work

 resistance to change by supervisor or colleagues

 lack of equipment or supplies

 no opportunity to apply practices

 nothing interfered

 other, please specify ___________________________________________________





A7f. Did any of these factors HELP you incorporate the STD practices recommended in the presentation?

(select all that apply

 reimbursement or other financial incentive

 support of supervisor and/or colleagues

 standing orders

 reminder in chart

 convenient supplies

 posted patient instructions for obtaining specimens

 nothing specific helped

 other, please specify ___________________________________________________


UseGuidef Do you use the CDC STD Treatment Guidelines to guide the care of your patients/clients?

No, I am not aware of the Guidelines

I am aware of the Guidelines but do not use them

I use the Guidelines occasionally

I use the Guidelines consistently

I use another source to guide my STD care (please specify) ______________


KG1f What is the CDC recommended treatment for a patient diagnosed with uncomplicated urethral

gonorrhea?

Ceftriaxone 250 mg intramuscularly only

Azithromycin 2 g orally in a single dose only

Ceftriaxone 250 mg intramuscularly plus azithromycin 1 g orally in a single dose

Cefixime 400 mg orally plus doxycycline 100 mg orally BID for 7 days

 

KSG1f What is the recommended follow-up for a non-pregnant patient after diagnosis and treatment

of chlamydia, gonorrhea, and/or trichomonas?

  A test of cure at 2 weeks, and repeat test at 3 months

A test of cure at 2 weeks, and repeat test at 12 months

Repeat test in 3 months

Repeat test in 12 months

 

KSG2f What is recommended for STD screening of an HIV-negative man who reports oral sex (oral and penile

exposure) and receptive anal sex with multiple male partners?

   Pharyngeal GC, rectal GC/CT, urethral GC/CT and syphilis every 3-6 months

Pharyngeal GC, Rectal GC/CT, urethral GC/CT and syphilis every 12-24 months

Urethral GC/CT and syphilis every 3-6 months, with pharyngeal GC and rectal GC/CT if symptoms are present

Urethral GC/CT and syphilis every 12-24 months, with pharyngeal GC and rectal GC/CT if symptoms are present



File Typeapplication/vnd.openxmlformats-officedocument.wordprocessingml.document
File TitleCourse Design and Delivery
Authordreisbach
File Modified0000-00-00
File Created2023-08-26

© 2024 OMB.report | Privacy Policy